Cargando…
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
BACKGROUND: The treatment of patients with haematological malignancies by means of haematopoietic stem cell transplantation (HSCT) is often accompanied by life threatening infections. With emerging antimicrobial resistance there is an increased need for new agents, with a beneficial safety profile....
Autores principales: | van der Velden, Walter JFM, van Iersel, Thijs MP, Blijlevens, Nicole MA, Donnelly, J Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746231/ https://www.ncbi.nlm.nih.gov/pubmed/19735580 http://dx.doi.org/10.1186/1741-7015-7-44 |
Ejemplares similares
-
Sensitization of KPC and NDM Klebsiella pneumoniae To Rifampicin by the Human Lactoferrin-Derived Peptide hLF1-11
por: Morici, Paola, et al.
Publicado: (2022) -
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11
por: Morici, Paola, et al.
Publicado: (2016) -
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species
por: Fais, Roberta, et al.
Publicado: (2022) -
In Vitro Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, against Susceptible and Drug-Resistant Mycobacterium tuberculosis and Its Synergistic Effect with Rifampicin
por: Intorasoot, Sorasak, et al.
Publicado: (2022) -
The goat β-casein/CMV chimeric promoter drives the expression of hLF in transgenic goats produced by cell transgene microinjection
por: Zhang, Ting, et al.
Publicado: (2019)